Functional Neuromodulation, Ltd. logo

Functional Neuromodulation, Ltd.

Functional Neuromodulation Ltd. (FNM) is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with mild Alzheimers and other memory and cognitive disorders.

FNM was founded by Andres Lozano, MD, scientific founder and principal inventor is investigating the use of DBS of the fornix (DBSf) to drive neural activity and modulate the brains memory circuit.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.fxneuromod.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
2 Oliver St., Suite 612109
Boston
United States
Email
Contact Number
+1 866 296 4040

Functional Neuromodulation Ltd. (FNM) is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with mild Alzheimers and other memory and cognitive disorders.

FNM was founded by Andres Lozano, MD, scientific founder and principal inventor is investigating the use of DBS of the fornix (DBSf) to drive neural activity and modulate the brains memory circuit.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/functional-neuromodulation” connections=”true” suffix=””]

Deep brain stimulation is a surgical treatment involving the implantation of a medical device called a brain pacemaker, which sends electrical impulses to specific parts of the brain reorganizing the brains electrical impulses leading to improvement.

FNM key investors include Genesys Capital, Foundation Medical Partners and Medtronic, Inc. The DBSf ADvance Study is also supported through a translational grant of up to $2.75M from the National Institute on Aging, part of the NIH.